Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Financials
Key financial figures for Tarsus Pharmaceuticals, Inc. Common Stock (Q1 2026).
- Revenue
- $162M
- Net Income
- -$7M
- EPS
- $-0.16
- Total Assets
- $581M
- Operating Cash Flow
- -$25M
Full income statement, balance sheet, and cash flow for Tarsus Pharmaceuticals, Inc. Common Stock on SentiSense.